Drugs / RV6153
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02517359 | Jul 2015 → Feb 2016 | asthma | Respivert Ltd | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RV6153 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02517359 ↗ |